In this study, we injected nanospheres containing a fluorescein derivative
into the vitreous cavity of pigmented rabbit eyes and evaluated their intra
ocular kinetics as drug carriers in vivo. Polystyrene nanospheres (2 mum, 2
00 nm and 50 nm in diameter) containing a fluorescein derivative were used
in this study. A suspension of each particle was prepared by diluting with
distilled water at a concentration of 10 mug/ml equivalent to sodium fluore
scein. The suspension of nanospheres was injected once into the vitreous ca
vity of unilateral eyes of pigmented rabbits. A sodium fluorescein solution
of the same concentration was injected once into the vitreous cavity of th
e other eye as the control. The intraocular kinetics of nanospheres was eva
luated by measuring vitreous fluorescence using a scanning fluorophotometer
. To investigate elimination pathways of nanospheres in detail, serial cros
s-sections of the eyes were examined with a fluorescence microscope. The fl
uorescence derived from nanospheres was observed in the vitreous cavity for
over 1 month (2 mum: t(1/2) = 5.4 +/- 0.8 days, 200 nm: t(1/2) = 8.6 +/- 0
.7 days, 50 nm: t(1/2) = 10.1 +/- 1.8 days), whereas that in the control ey
es completely disappeared within 3 days (t(1/2) = 7.8 +/- 0.7 h). The elimi
nation half-life from the vitreous cavity correlated well with the particle
diameter (r = -0.997, P = 0.007). Histological studies using a fluorescenc
e microscope revealed that nanospheres with a diameter of 2 mum were seen i
n the vitreous cavity and trabecular meshwork, while nanospheres with a dia
meter of smaller than 200 nm were also observed in the retina as well as th
ese tissues. Our findings indicated that nanospheres may be beneficial as a
drug carrier to the retina, vitreous and trabecular meshwork. Copyright (C
) 2001 S. Karger AG, Basel.